Key facts
- Unlimited Tomorrow’s last known valuation is $30.0M (Nov 2022).
- It has raised $10.7M across 2 recorded rounds; the latest was Seed Round ($2.0M) in Nov 2022.
- Notable investors include Microsoft, Prime Movers Lab, ASU ScaleU, Chino Lex, Dassault Systèmes BIOVIA — 11 tracked in total.
- Unlimited Tomorrow has filed 2 Form Ds with the SEC since 2019, most recently Nov 2022 ($2.0M sold to 15 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Unlimited Tomorrow
Funding rounds
2 roundsAbout Unlimited Tomorrow
Developer of a prosthetic technology designed to offer artificial limbs. The company's technology automatically tailors the design of an artificial limb to the shape and dimension of a person by using 3D scanners that digitally map an amputee's residual limb and opposite full arm, enabling differently-abled people in remote and underprivileged communities to gain access to affordable prosthetic arms.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2014
- Employees
- 12
- Website
- tactraflex.com/
- Ownership
- Privately Held (backing)
Unlimited Tomorrow doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Unlimited Tomorrow shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Unlimited Tomorrow in its N-PORT filings yet. We sweep new filings monthly.